• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性HIV感染的早期治疗与死亡率降低相关。

Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality.

作者信息

Pinto Angie N, Grey Pat, Shaik Ansari, Cooper David A, Kelleher Anthony D, Petoumenos Kathy

机构信息

The Kirby Institute , UNSW Sydney, Sydney, Australia .

出版信息

AIDS Res Hum Retroviruses. 2018 Nov;34(11):936-941. doi: 10.1089/AID.2017.0284. Epub 2018 Jul 17.

DOI:10.1089/AID.2017.0284
PMID:29901415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6238611/
Abstract

The aim of this study was to understand factors associated with increased mortality in a cohort of primary HIV infection (PHI) in New South Wales (NSW) over three decades. Six hundred and two patients with PHI were enrolled from 1984 to 2009. Probabilistic data linkage was performed to NSW Registry of births deaths and marriages and Australian Bureau of Statistics mortality database. Mortality was measured by crude death rate. Pre highly active antiretroviral therapy (pre-HAART) era was defined as before January 1, 1997. A Cox proportional hazard model was used to identify factors associated with death. One hundred and thirty-eight deaths occurred during 6,223 person years (PY) follow-up. Overall crude death rate was 2.2 per 100 PY (95% confidence interval [CI], 1.9-2.6), 3.6 (95% CI, 3.1-4.3)in pre-HAART era and 0.20 (95% CI, 0.08-0.47) in post-HAART era. AIDS was the most frequent cause of death (52%, 72/138), all occurring in the pre-HAART era. Of non-AIDS deaths, the leading known cause was non-AIDS cancer 8% (11/138) followed by suicide 4% (6/138). On multivariate analysis, estimated date of infection in pre-HAART era and time to commencement of ART greater than 1 year post diagnosis were more likely to be associated with death (p < .05). Mortality in PHI has decreased significantly in the post-HAART era. Non-AIDS deaths due to malignancy and suicide are emerging as leading causes in this population in the post-HAART era. Time to starting ART greater than 1 year was associated with increased mortality.

摘要

本研究旨在了解新南威尔士州(NSW)三十年期间原发性HIV感染(PHI)队列中与死亡率增加相关的因素。1984年至2009年纳入了602例PHI患者。对新南威尔士州出生、死亡和婚姻登记处以及澳大利亚统计局死亡率数据库进行了概率数据链接。死亡率通过粗死亡率衡量。高效抗逆转录病毒治疗(HAART)前时代定义为1997年1月1日之前。使用Cox比例风险模型确定与死亡相关的因素。在6223人年(PY)的随访期间发生了138例死亡。总体粗死亡率为每100 PY 2.2例(95%置信区间[CI],1.9 - 2.6),HAART前时代为3.6例(95% CI,3.1 - 4.3),HAART后时代为0.20例(95% CI,0.08 - 0.47)。艾滋病是最常见的死亡原因(52%,72/138),均发生在HAART前时代。在非艾滋病死亡中,已知的主要原因是非艾滋病癌症8%(11/138),其次是自杀4%(6/138)。多变量分析显示,HAART前时代的估计感染日期以及诊断后开始抗逆转录病毒治疗(ART)的时间超过1年更有可能与死亡相关(p < 0.05)。在HAART后时代,PHI的死亡率显著下降。在HAART后时代,恶性肿瘤和自杀导致的非艾滋病死亡正在成为该人群的主要死因。开始ART的时间超过1年与死亡率增加相关。

相似文献

1
Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality.原发性HIV感染的早期治疗与死亡率降低相关。
AIDS Res Hum Retroviruses. 2018 Nov;34(11):936-941. doi: 10.1089/AID.2017.0284. Epub 2018 Jul 17.
2
Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.1984 - 2005年台湾地区HIV感染患者的死亡率及死亡原因趋势
HIV Med. 2008 Aug;9(7):535-43. doi: 10.1111/j.1468-1293.2008.00600.x. Epub 2008 Jun 28.
3
Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.1984年至2003年加拿大艾伯塔省南部HIV感染者的死亡率及死亡原因变化情况
HIV Med. 2005 Mar;6(2):99-106. doi: 10.1111/j.1468-1293.2005.00271.x.
4
Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.高效抗逆转录病毒治疗时代城市中感染艾滋病毒及有吸毒风险人群队列中的死亡率
Clin Infect Dis. 2005 Sep 15;41(6):864-72. doi: 10.1086/432883. Epub 2005 Aug 16.
5
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.高效抗逆转录病毒治疗时代的死亡率:HIV门诊研究中死亡和疾病原因的变化
J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34. doi: 10.1097/01.qai.0000233310.90484.16.
6
Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.HIV感染者的死因及死亡率比较:高效抗逆转录病毒治疗前、早期和晚期阶段的分析
J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):194-200. doi: 10.1097/01.qai.0000179459.31562.16.
7
Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort.在高效抗逆转录病毒治疗时代,与普通人群相比,诊断出 HIV 的人群的死亡率和死因:一项全国性观察队列分析。
Lancet Public Health. 2017 Jan;2(1):e35-e46. doi: 10.1016/S2468-2667(16)30020-2. Epub 2016 Dec 15.
8
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.有效的治疗改变了HIV血清转化后特定病因死亡率的分布情况。
AIDS. 2006 Mar 21;20(5):741-9. doi: 10.1097/01.aids.0000216375.99560.a2.
9
Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.塞内加尔接受高效抗逆转录病毒治疗的成年人的死亡率和死亡原因:一项为期7年的队列研究。
AIDS. 2006 May 12;20(8):1181-9. doi: 10.1097/01.aids.0000226959.87471.01.
10
Determinants of survival following HIV-1 seroconversion after the introduction of HAART.高效抗逆转录病毒治疗(HAART)引入后HIV-1血清转化后的生存决定因素。
Lancet. 2003 Oct 18;362(9392):1267-74. doi: 10.1016/s0140-6736(03)14570-9.

引用本文的文献

1
Global overview of suicidal behavior and associated risk factors among people living with human immunodeficiency virus: A scoping review.全球范围内人类免疫缺陷病毒感染者自杀行为及相关风险因素概述:范围综述。
PLoS One. 2023 Mar 20;18(3):e0269489. doi: 10.1371/journal.pone.0269489. eCollection 2023.
2
The first 90: Progress in HIV detection in Zhejiang Province, 2008-2018.《2008-2018 年浙江省艾滋病检测工作进展》。
PLoS One. 2021 Apr 8;16(4):e0249517. doi: 10.1371/journal.pone.0249517. eCollection 2021.
3
Avoiding Drug Resistance in HIV Reverse Transcriptase.避免 HIV 逆转录酶的耐药性。
Chem Rev. 2021 Mar 24;121(6):3271-3296. doi: 10.1021/acs.chemrev.0c00967. Epub 2021 Jan 28.
4
How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.在接受联合抗逆转录病毒治疗的病毒学抑制的 HIV 阳性个体中,单核细胞如何导致动脉粥样硬化风险增加。
Front Immunol. 2019 Jun 19;10:1378. doi: 10.3389/fimmu.2019.01378. eCollection 2019.
5
Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors.嘧啶 2,4-二酮类在新型 HIV RT 抑制剂设计中的应用。
Molecules. 2019 May 2;24(9):1718. doi: 10.3390/molecules24091718.

本文引用的文献

1
Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort.在高效抗逆转录病毒治疗时代,与普通人群相比,诊断出 HIV 的人群的死亡率和死因:一项全国性观察队列分析。
Lancet Public Health. 2017 Jan;2(1):e35-e46. doi: 10.1016/S2468-2667(16)30020-2. Epub 2016 Dec 15.
2
Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis.接受抗逆转录病毒治疗的HIV感染者中非艾滋病相关死亡原因的患病率及分布:一项系统评价和荟萃分析
Int J STD AIDS. 2017 Jun;28(7):636-650. doi: 10.1177/0956462416632428. Epub 2016 Feb 10.
3
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.早期无症状HIV感染中抗逆转录病毒治疗的启动
N Engl J Med. 2015 Aug 27;373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20.
4
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.1999 年至 2011 年期间艾滋病毒感染者的死亡根本原因趋势(D:A:D):多队列协作研究。
Lancet. 2014 Jul 19;384(9939):241-8. doi: 10.1016/S0140-6736(14)60604-8.
5
Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.依法韦仑作为HIV-1感染初始治疗与自杀意念、自杀未遂或自杀死亡风险增加之间的关联:试验数据分析
Ann Intern Med. 2014 Jul 1;161(1):1-10. doi: 10.7326/M14-0293.
6
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.早期启动抗逆转录病毒治疗中断后实现长期病毒学缓解的治疗后HIV-1控制者:ANRS VISCONTI研究
PLoS Pathog. 2013 Mar;9(3):e1003211. doi: 10.1371/journal.ppat.1003211. Epub 2013 Mar 14.
7
Short-course antiretroviral therapy in primary HIV infection.原发性 HIV 感染的短程抗逆转录病毒治疗。
N Engl J Med. 2013 Jan 17;368(3):207-17. doi: 10.1056/NEJMoa1110039.
8
Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.抗逆转录病毒治疗长达 15 年的 HIV 阳性患者的长期生存。
PLoS One. 2012;7(11):e48839. doi: 10.1371/journal.pone.0048839. Epub 2012 Nov 7.
9
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study.瑞士艾滋病毒队列研究中死亡率的下降和死因模式的变化。
HIV Med. 2013 Apr;14(4):195-207. doi: 10.1111/j.1468-1293.2012.01051.x. Epub 2012 Sep 24.
10
The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.设定点研究(ACTG A5217):即刻与延迟抗逆转录病毒治疗对近期 HIV-1 感染者病毒学设定点的影响。
J Infect Dis. 2012 Jan 1;205(1):87-96. doi: 10.1093/infdis/jir699. Epub 2011 Dec 15.